OLIGOMED: Oligonucleotides for Medical Applications
KRZYSZTOF KUCHARCZYK TECHNIKI ELEKTROFORETYCZNE SPZOO
participó en un
H2020
H2020-MSCA-ITN-2020
The use of synthetic oligonucleotides (ONs, short DNA or RNA strands) in the treatment of genetic diseases is a rapidly growing field, and t...
2020-08-13 - 2025-06-30 | Financiado
2020-08-13 - 2025-06-30 | Financiado
CURELUNG: Determining epi genetic therapeutic signatures for improving lung cancer prognosis
KRZYSZTOF KUCHARCZYK TECHNIKI ELEKTROFORETYCZNE SPZOO
participó en un
FP7
Lung cancer (LC) is still the most lethal type of cancer worldwide. The extremely poor prognosis for LC patients is partly due to the lack o...
Financiado
Financiado
* No se disponen de datos de la empresa actual.